AVANCE CLINICAL
LIVE

Serial Number

79290707

Owner

Avance Clinical Pty Ltd

Attorney

David L. May

Filing Date

Jun 9, 2020

Add to watchlist:

No watchlists yet
View on USPTO

AVANCE CLINICAL Trademark

Serial Number: 79290707 • Registration: 6549556

AVANCE CLINICAL is a trademark filed by Avance Clinical Pty Ltd on June 9, 2020. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Avance Clinical Pty Ltd (4 trademarks)

213 Glynburn Road

Entity Type: 99

Trademark Details

Filing Date

June 9, 2020

Registration Date

November 9, 2021

Published for Opposition

August 24, 2021

Goods & Services

Advisory services relating to pharmacology; advisory services relating to product testing; advisory services relating to science in the field of pharmacology; advisory services relating to scientific research; development of software systems for the processing of data; development of testing methods in the field of pharmacology; conducting clinical trials for others; conducting clinical trials for others in the field of pharmacology; conducting technical project studies in the field of pharmacology; consultancy pertaining to pharmacology; medical research; pharmaceutical research services; preparation of reports relating to scientific research; preparation of statistics for scientific research, namely, preparation of technical reports and analyses of statistical data for scientific research; provision of information relating to scientific research; Product quality testing; research relating to biotechnology; research relating to data processing; research relating to medicine; research relating to pharmaceuticals; scientific and technical analysis in the field of pharmacology; scientific consultancy services relating to pharmacology; scientific testing services in the field of pharmacology; services for assessing the efficiency of pharmaceuticals; services for assessing the safety of pharmaceuticals; technical data analysis services in the field of pharmacology; testing of products

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 17, 2024 ADCH
FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE
Apr 28, 2022 FINA
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 9, 2022 FICR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 29, 2022 FINO
REGISTERED-PRINCIPAL REGISTER
Nov 9, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 24, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 24, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Aug 22, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 4, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 4, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 4, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 22, 2021 CNSA
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
May 17, 2021 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
May 17, 2021 PARI
NOTIFICATION PROCESSED BY IB
May 11, 2021 GPNX
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 29, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 28, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 28, 2021 TROA
DIVISIONAL PROCESSING COMPLETE
Mar 11, 2021 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 11, 2021 AITU
DIVISIONAL REQUEST RECEIVED
Feb 5, 2021 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Feb 5, 2021 ERTD
REFUSAL PROCESSED BY IB
Nov 14, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 28, 2020 RFCS
REFUSAL PROCESSED BY MPU
Oct 28, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 6, 2020 RFCR
NON-FINAL ACTION WRITTEN
Oct 5, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 10, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 7, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 3, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 30, 2020 REPR